Get started
INVO BioScience, Inc.INVO BioScience, Inc.INVO BioScience, Inc.

INVO BioScience, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

INVO chart


Full chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.56 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.5448USD
Net income (FY)
‪−8.03 M‬USD
Revenue (FY)
‪3.02 M‬USD
Shares float
‪3.88 M‬
Beta (1Y)
−3.45

Employees


Employees (FY)
30
Revenue / Employee (1Y)
‪100.69 K‬USD
Net income / Employee (1Y)
‪−267.82 K‬USD

About INVO BioScience, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Steven M. Shum
Website
invobioscience.com
Headquarters
Sarasota
Founded
2007
FIGI
BBG000GHH9P9
INVO BioScience, Inc. is a fertility company. It focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Sarasota, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

News



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Analyze a symbol's price movements over past years with our seasonal tools, helping you spot repeating annual trends and better gauge potential market patterns.

Frequently Asked Questions


The current price of INVO is 1.2400 USD — it has decreased by −4.03% in the past 24 hours. Watch INVO BioScience, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange INVO BioScience, Inc. stocks are traded under the ticker INVO.
INVO stock has fallen by −5.76% compared to the previous week, the month change is a −6.43% fall, over the last year INVO BioScience, Inc. has showed a 76.39% increase.
INVO reached its all-time high on Nov 28, 2008 with the price of 5,440.0000 USD, and its all-time low was 0.5000 USD and was reached on Oct 19, 2023. View more price dynamics on INVO chart.
See other stocks reaching their highest and lowest prices.
INVO stock is 118.36% volatile and has beta coefficient of −3.45. Track INVO BioScience, Inc. stock price on the chart and check out the list of the most volatile stocks — is INVO BioScience, Inc. there?
Today INVO BioScience, Inc. has the market capitalization of ‪2.56 M‬, it has decreased by −1.41% over the last week.
Yes, you can track INVO BioScience, Inc. financials in yearly and quarterly reports right on TradingView.
INVO BioScience, Inc. is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
INVO earnings for the last quarter are −0.62 USD per share, whereas the estimation was −0.14 USD resulting in a −342.86% surprise. The estimated earnings for the next quarter are −0.09 USD per share. See more details about INVO BioScience, Inc. earnings.
INVO BioScience, Inc. revenue for the last quarter amounts to ‪1.84 M‬ USD, despite the estimated figure of ‪3.27 M‬ USD. In the next quarter, revenue is expected to reach ‪4.04 M‬ USD.
INVO net income for the last quarter is ‪−2.25 M‬ USD, while the quarter before that showed ‪−1.60 M‬ USD of net income which accounts for −40.63% change. Track more INVO BioScience, Inc. financial stats to get the full picture.
No, INVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 15, 2024, the company has 30.00 employees. See our rating of the largest employees — is INVO BioScience, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INVO BioScience, Inc. EBITDA is ‪−4.62 M‬ USD, and current EBITDA margin is −217.38%. See more stats in INVO BioScience, Inc. financial statements.
Like other stocks, INVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INVO BioScience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INVO BioScience, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INVO BioScience, Inc. stock shows the sell signal. See more of INVO BioScience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.